Skip to content
Open access

An Optical Biosensor for Label-Free Detection of Soluble Biomarker: Toward Minimally Invasive Breast Cancer Monitoring

Sep 2026 · Oncology, Nuclear Medicine and Transplantology · 0 citations

TL;DR

The development of a graphene oxide-coated fiber-optic biosensor based on a semi-distributed interferometric sensing platform for the highly sensitive detection of solCD44, a cell adhesion glycoprotein whose soluble form is elevated in several cancers including breast cancer, is reported.

Abstract

Tumor cells release biomarkers such as CD44 into the bloodstream, offering opportunities for minimally invasive monitoring of tumor progression. However, conventional analytical methods often suffer from insufficient sensitivity and a limited dynamic range, which hinders reliable detection of such biomarkers in complex biological fluids. Optical fiber biosensors are particularly attractive alternatives, offering high sensitivity, low cost, chemical inertness, and diverse surface functionalization strategies, making them well suited for detecting clinically relevant circulating tumor biomarkers that require sensitive, quantitative analysis. CD44, a cell adhesion glycoprotein whose soluble form (solCD44) is elevated in several cancers including breast cancer (BC), was selected as a model biomarker for this study owing to its well-established diagnostic relevance. Here, we report the development of a graphene oxide-coated fiber-optic biosensor based on a semi-distributed interferometric sensing platform for the highly sensitive detection of solCD44. A total of 46 sensors were fabricated and characterized for their sensitivity to refractive index changes in the surrounding medium. The sensor surface was subsequently functionalized with anti-CD44 antibodies, and successful biofunctionalization together with antibody specificity was confirmed using several complementary techniques, including atomic force microscopy (AFM) and ELISA. The optimized biosensor exhibited a wide dynamic detection range, spanning attomolar concentrations up to 100 nM, with a limit of detection (LOD) as low as 175 aM in spiked serum. Specificity was confirmed by comparison with non-functionalized sensors and healthy control samples. To validate its practical clinical applicability, the biosensor was further tested in human serum samples from breast cancer patients, showing significantly higher signal in cancer patients than in healthy controls. Successful detection of solCD44 in urine additionally demonstrated the biosensor's compatibility with multiple biological matrices. Together, these findings establish this fiber-optic biosensor as a promising platform for highly sensitive, label-free, and minimally invasive detection of cancer biomarkers, with strong potential for clinical translation and point-of-care diagnostic systems.

Read PDF

Similar papers

Review Sep 2026

Translational optical and electrochemical biosensing strategies for liquid biopsy in triple-negative breast Cancer: advances, challenges, and clinical implementation.

This review systematically correlates TNBC biomarkers with optimal sensing technologies, emphasizing how biomolecular properties affect sensor selection and performance and emphasizes future integration of biosensors with CTC-derived organoids, microfluidics, AI, and multiplexed detection to enable portable, clinically...

Karim G. Mohammed, M. Abdelgawad, Mohamed S. Attia · 0 citations
Sep 2026

Fiber Optic Biosensors for Triple-Negative Breast Cancer Cells Detection

The developed fiber-optic biosensors show potential for integration into liquid biopsy platforms for label-free detection of circulating tumor cells in biological fluids, providing a rapid and minimally invasive approach for cancer detection and monitoring.

Aigerim Omirzakova, Lyazzat Mukhangaliyeva, Marzhan Nurlankyzy et al. · 0 citations
Oct 2026

Nano-colorimetric sensing coupled with a smartphone platform for highly sensitive detection of MDA-MB-231 cells.

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer (BC), and the precise detection of MDA-MB-231 cells is important for the early diagnosis, disease monitoring, and evaluation of treatment efficacy in TNBC. However, traditional detection methods have disadvantages such as compl...

Jiao-Yan Qiu, Ying-Qi Chen, Yuan-Fei Wang et al. · 0 citations
Review Open access Aug 2026

Recent advances in biosensors for cancer diagnosis and analytical strategies

This review summarizes relevant biosensor types, including electrochemical, optical, mass-sensitive, microfluidic, nano-biosensors (recently developed), and hydrogel-based systems with discussion of their underlying analytical principles and performance for clinically important cancer biomarkers.

Shruti Patil, Hemant Kumar Tatapudi, Kishore Raju Vatsavai et al. · 0 citations
Open access Aug 2026

Label-Free Refractive-Index-Based Detection of Breast, Leukemia, and Prostate Cancer Cells Using a Tetra-Core PCF SPR Biosensor

In this research, a high-performance plasmonic refractive index (RI) biosensor based on an external metal deposition (EMD) technique and photonic crystal fiber (PCF) platform for potential cancer detection is presented, investigated, and linked with real-time cancer cells. Variations in the RI of biological fluids are...

A. K. Shakya, M. Grigalavičius · 3 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.